O
ALGN icon

OrbiMed’s Align Technology ALGN Stock Holding History

OrbiMed’s Portfolio ALGN Stock Details ALGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-766,000
Closed -$36.8M – 122
2013
Q3 		$36.8M Sell
766,000
-58,000
-7% -$2.53M 0.66% 40
2013
Q2 		$30.5M Buy
+824,000
New +$28.4M 0.65% 36

Other funds holding ALGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.65B AUM 23.83% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

OrbiMed's ALGN Position: Q4 2013 in Review

OrbiMed sold out of Align Technology (ALGN) in Q4 2013, closing a stake of 766,000 shares — an estimated $36.8M sold.

OrbiMed first reported a position in ALGN in Q2 2013 and held it in 2 quarters. The position peaked at $36.8M in Q3 2013. 248 funds tracked by Wall St. Rank hold ALGN as of Q4 2013.

  • OrbiMed reported no remaining Align Technology position as of Q4 2013 after selling out during the quarter.
  • OrbiMed sold 766,000 Align Technology shares in Q4 2013, an estimated $36.8M.
  • OrbiMed first reported a position in Align Technology in Q2 2013 and held it in 2 quarters.
  • OrbiMed's Align Technology position peaked at $36.8M in Q3 2013.
  • 248 funds tracked by Wall St. Rank held Align Technology as of Q4 2013.

Based on OrbiMed's 13F filing for Q4 2013, filed 14 Feb 2014.